Compare GSL & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GSL | PLSE |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | Greece | United States |
| Employees | 11 | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | N/A | 2015 |
| Metric | GSL | PLSE |
|---|---|---|
| Price | $36.66 | $20.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $43.50 | $22.00 |
| AVG Volume (30 Days) | ★ 397.7K | 216.2K |
| Earning Date | 03-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.56% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $840.00 |
| Revenue Next Year | N/A | $287.54 |
| P/E Ratio | $3.49 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.73 | $12.56 |
| 52 Week High | $41.40 | $26.30 |
| Indicator | GSL | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 40.85 | 50.37 |
| Support Level | $35.03 | $13.75 |
| Resistance Level | $37.06 | $23.18 |
| Average True Range (ATR) | 0.97 | 1.45 |
| MACD | -0.19 | -0.10 |
| Stochastic Oscillator | 2.84 | 44.13 |
Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.